These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25579138)

  • 1. Role of matrix metalloproteinases in physiological processes & disease.
    Ravi Kanth VV; Nageshwar Reddy D
    Indian J Med Res; 2014 Nov; 140(5):585-7. PubMed ID: 25579138
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased matrix metalloproteinase expression and activation following experimental acute pancreatitis.
    Muhs BE; Patel S; Yee H; Marcus S; Shamamian P
    J Surg Res; 2001 Nov; 101(1):21-8. PubMed ID: 11676550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does matrix metalloproteinase activity predict severity of acute pancreatitis?
    Aynaci M; Tuncyurek P; Nart D; Zeytunlu M; Ozutemiz O; Ersoz G; Yilmaz F; Mayer J; Coker A
    ANZ J Surg; 2006 Sep; 76(9):801-4. PubMed ID: 16922902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of matrix metalloproteinases in skin ageing.
    Sárdy M
    Connect Tissue Res; 2009; 50(2):132-8. PubMed ID: 19296304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Matrix metalloproteinases and atherosclerosis. Therapeutic aspects].
    Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
    Ann Biol Clin (Paris); 2003; 61(2):147-58. PubMed ID: 12702469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of matrix metalloproteinases in patients with Wegener's granulomatosis.
    Bjerkeli V; Halvorsen B; Damås JK; Nordøy I; Yndestad A; Aukrust P; Frøland SS
    Ann Rheum Dis; 2004 Dec; 63(12):1659-63. PubMed ID: 15547092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extracellular matrix metalloproteinases. Part II].
    Krześniak-Wszoła N; Bielecki K
    Pol Merkur Lekarski; 2006 Feb; 20(116):223-7. PubMed ID: 16708646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of matrix metalloproteinases and their tissue inhibitors in serum produces doubtful results.
    Jung K
    J Infect Dis; 2008 Dec; 198(11):1722-3; author reply 1723-4. PubMed ID: 19000015
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical significance of serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in chronic liver disease.
    Watanabe N; Nishizaki Y; Kojima S; Takashimizu S; Nagata N; Kagawa T; Shiraishi K; Mine T; Matsuzaki S
    Tokai J Exp Clin Med; 2006 Sep; 31(3):96-101. PubMed ID: 21302232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preanalytical biases in measurement of matrix metalloproteinases and their tissue inhibitors in peripheral blood.
    Jung K
    J Rheumatol; 2007 Apr; 34(4):890-2; author reply 892. PubMed ID: 17407248
    [No Abstract]   [Full Text] [Related]  

  • 11. Matrix metalloproteinases in cerebrovascular diseases.
    Fatar M; Stroick M; Griebe M; Hennerici M
    Cerebrovasc Dis; 2005; 20(3):141-51. PubMed ID: 16088108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of the levels of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the early phase of cerebral ischemia.
    Lorenzl S; De Pasquale G; Segal AZ; Beal MF
    Stroke; 2003 Jun; 34(6):e37-8; author reply e37-8. PubMed ID: 12750528
    [No Abstract]   [Full Text] [Related]  

  • 13. Sample processing and its preanalytical impact on the measurement of circulating matrix metalloproteinases.
    Jung K
    Clin Chem Lab Med; 2006; 44(4):500-2. PubMed ID: 16599848
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation between heavy alcohol consumption and elevation of matrix metalloproteinases.
    Forough R
    Eur J Clin Invest; 2002 Apr; 32(4):219-20. PubMed ID: 11952803
    [No Abstract]   [Full Text] [Related]  

  • 15. Matrix metalloproteinases in plants: a brief overview.
    Marino G; Funk C
    Physiol Plant; 2012 May; 145(1):196-202. PubMed ID: 22084906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies.
    Fainardi E; Castellazzi M; Bellini T; Dallocchio F
    Mult Scler; 2007 May; 13(4):561-2. PubMed ID: 17463079
    [No Abstract]   [Full Text] [Related]  

  • 17. Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies.
    Fainardi E; Castellazzi M; Bellini T; Dallocchio F
    Mult Scler; 2007 Jun; 13(5):691-2. PubMed ID: 17615626
    [No Abstract]   [Full Text] [Related]  

  • 18. Matrix metalloproteinases as markers of adverse remodeling after myocardial infarction.
    Jugdutt BI
    J Card Fail; 2006 Feb; 12(1):73-6. PubMed ID: 16500584
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum samples are inappropriate for use in measuring circulating matrix metalloproteinases: comment on the article by Young-Min et al.
    Jung K
    Arthritis Rheum; 2008 May; 58(5):1557-8; author reply 1559. PubMed ID: 18438823
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases levels in pediatric patients with congenital heart disease: Relationship to cardiac functions.
    Kiliç Z; Uçar B; Özdemir G; Colak Ö; Bal C; Ertuğrul T
    Anadolu Kardiyol Derg; 2014 Sep; 14(6):531-41. PubMed ID: 25233500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.